What is Nubeqa?
Nubeqa is an androgen receptor inhibitor used to treat specific types of prostate cancer in men. Its generic name is darolutamide. This medication is specifically approved for non-metastatic castration-resistant prostate cancer (nmCRPC). It is also approved for metastatic hormone-sensitive prostate cancer (mHSPC). Nubeqa helps slow down the spread and growth of cancer. It targets the hormones that can make cancer cells grow faster. This action makes it a key part of modern prostate cancer treatment.
How does Nubeqa work?
Nubeqa works by blocking male hormones, known as androgens, from fueling cancer cell growth. Testosterone is the most well-known androgen. Prostate cancer cells use these hormones to grow and multiply. Nubeqa attaches to the androgen receptors on these cells. This prevents the hormones from binding to them. By cutting off this fuel supply, the medication effectively slows down or stops cancer progression. Its unique structure is designed to limit passage into the brain. This may help reduce certain central nervous system side effects.
Who is Nubeqa for?
Nubeqa is for adult men diagnosed with certain forms of advanced prostate cancer. Your doctor may prescribe it if you have non-metastatic castration-resistant prostate cancer (nmCRPC). This means the cancer is not responding to standard testosterone-lowering treatments but has not yet spread. It is also for men with metastatic hormone-sensitive prostate cancer (mHSPC). This means the cancer has spread but still responds to hormone therapy. For mHSPC, it is often given with the chemotherapy drug docetaxel.
Dosage and administration
Nubeqa is typically administered as two 300 mg tablets taken together twice a day. This equals a total daily dose of 1200 mg. You should always take your tablets with food. Swallow them whole with a full glass of water. Do not split, crush, or chew the tablets. Consistency is very important for this medication. Try to take your doses at the same times each day. For patients with certain liver or kidney problems, a doctor may prescribe a lower dose. Never stop taking Nubeqa without consulting your healthcare provider.
Side effects
Nubeqa may cause side effects, though many people experience only mild effects or none at all. Because it is a targeted therapy, its side effect profile is often more tolerable than traditional chemotherapy. Your doctor prescribes Nubeqa because the benefits are greater than the risks. You should still be aware of possible effects. Common side effects can include:
- Fatigue or extreme tiredness
- Skin rash
- Pain in arms, legs, hands, or feet
- Decreased white blood cell counts (neutropenia)
Your doctor will monitor for changes with regular blood tests. This helps track liver function and blood cell counts. Contact your doctor if any side effect persists or worsens.
Why buy from IsraelPharm?
IsraelPharm provides a reliable and affordable way to get your prescribed Nubeqa medication. We are committed to making essential medications accessible to patients in the United States. When you order from us, you get genuine products sourced from a licensed pharmacy. Our team of experienced pharmacists is available to answer your questions. We ensure your medication is shipped directly to your door safely and discreetly. Choose IsraelPharm for competitive pricing, excellent customer service, and peace of mind for your treatment needs.
Most individuals using Nubeqa do not experience severe side effects. The benefits of treatment are considered to outweigh the risks. However, some common side effects may include:
- Fatigue or weakness
- Skin rash
- Anemia (low red blood cell count)
- Pain in extremities (arms, legs, hands, feet)
- Changes in liver function tests
This is not a complete list. Always consult a healthcare professional for medical advice and to report any persistent symptoms.
Nubeqa (darolutamide) is indicated for the treatment of adult men with:
- Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC): For cancer that no longer responds to testosterone-lowering therapies but has not spread to other body parts.
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): For cancer that has spread but still responds to hormone therapy, often used with docetaxel chemotherapy.